Table 2. Kaplan-Meier univariable analysis.
| Variables | Median overall survival (months) | P value |
|---|---|---|
| Sex | ||
| Female | NA* | 0.067 |
| Male | 35 | |
| Age (years) | ||
| ≤60 | 63 | 0.479 |
| >60 | 57 | |
| Smoking status | ||
| Never | 63 | 0.367 |
| Even or current | 46 | |
| Smoking index | ||
| ≤800 | 63 | 0.002 |
| >800 | 20 | |
| Tumor location | ||
| Peripheral | 63 | 0.231 |
| Central | 20 | |
| Neoadjuvant therapy | ||
| No | 63 | 0.36 |
| Yes | 31 | |
| Surgical resection method | ||
| Pulmonary lobectomy | 63 | 0.124 |
| Other pneumoresection | 27 | |
| Histological subtype | ||
| P-SCLC | 46 | 0.375 |
| C-SCLC | NA* | |
| Pathological TNM stage | 0.01 | |
| Stage I vs. stage II | NA | 0.003 |
| Stage I vs. stage III | 20 | 0.019 |
| Stage II vs. stage III | 46 | 0.332 |
| Postoperative chemotherapy | ||
| ≤4 courses | 35 | 0.003 |
| >4 courses | NA* | |
| Postoperative radiotherapy | ||
| No | 57 | 0.886 |
| Yes | NA* |
NA*, cumulative survival rate was greater than 50% across the entire survival curve. C-SCLC, mixed histology small cell lung cancer; P-SCLC, pure small cell lung cancer.